research Simultaneous HBV Reactivation and Hair Discoloration Under Secukinumab Treatment.
In this case report, a 36-year-old patient undergoing secukinumab treatment for psoriasis experienced both hepatitis B reactivation and hair discoloration, suggesting a potential link between these effects, though further studies are needed to understand this relationship.




